Bank Julius Baer & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153M | Sell |
376,568
-103,825
| -22% | -$42.1M | 0.45% | 62 |
|
|
2025
Q1 | $239M | Buy |
480,393
+37,565
| +8% | +$18.7M | 0.78% | 39 |
|
|
2024
Q4 | $248M | Buy |
442,828
+3,015
| +0.7% | +$1.69M | 0.77% | 31 |
|
|
2024
Q3 | $311M | Sell |
439,813
-21,298
| -5% | -$15.1M | 1.05% | 26 |
|
|
2024
Q2 | $278M | Sell |
461,111
-35,113
| -7% | -$21.2M | 1.06% | 25 |
|
|
2024
Q1 | $287M | Buy |
496,224
+69,229
| +16% | +$40.1M | 1.1% | 22 |
|
|
2023
Q4 | $264M | Sell |
426,995
-4,820
| -1% | -$2.98M | 1.12% | 21 |
|
|
2023
Q3 | $219M | Buy |
431,815
+22,269
| +5% | +$11.3M | 1.27% | 22 |
|
|
2023
Q2 | $214M | Buy |
409,546
+6,628
| +2% | +$3.46M | 1.27% | 24 |
|
|
2023
Q1 | $232M | Sell |
402,918
-9,861
| -2% | -$5.68M | 1.48% | 17 |
|
|
2022
Q4 | $227M | Sell |
412,779
-64,334
| -13% | -$35.4M | 1.55% | 18 |
|
|
2022
Q3 | $242M | Sell |
477,113
-72,699
| -13% | -$36.9M | 1.84% | 14 |
|
|
2022
Q2 | $299M | Sell |
549,812
-164,465
| -23% | -$89.4M | 2.11% | 10 |
|
|
2022
Q1 | $422M | Buy |
714,277
+30,793
| +5% | +$18.2M | 2.53% | 8 |
|
|
2021
Q4 | $456M | Buy |
683,484
+32,762
| +5% | +$21.9M | 2.44% | 8 |
|
|
2021
Q3 | $372M | Buy |
650,722
+40,866
| +7% | +$23.3M | 2.31% | 9 |
|
|
2021
Q2 | $308M | Buy |
609,856
+18,413
| +3% | +$9.29M | 1.95% | 11 |
|
|
2021
Q1 | $270M | Sell |
591,443
-50,478
| -8% | -$23M | 2.02% | 10 |
|
|
2020
Q4 | $299M | Buy |
641,921
+530,026
| +474% | +$247M | 2.45% | 10 |
|
|
2020
Q3 | $49.4M | Buy |
111,895
+108,195
| +2,924% | +$47.8M | 0.48% | 51 |
|
|
2020
Q2 | $40.7M | Sell |
3,700
-106,660
| -97% | -$1.17B | 0.47% | 52 |
|
|
2020
Q1 | $31.3M | Buy |
+110,360
| New | +$31.3M | 0.72% | 40 |
|